Treatment with octreotide to suppress corticotropin secretion by a carcinoid tumour

被引：0
|
作者：
Tirovola, EB
Malpas, JS
机构：
[1] Univ Athens, Sch Med, Dept Internal Med & Nosol 1, GR-11527 Athens, Greece
[2] Univ London St Bartholomews Hosp Med Coll, Dept Med Oncol, London EC1 1BB, England
来源：
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE | 2005年 / 98卷 / 11期
关键词：
D O I：
10.1258/jrsm.98.11.516
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Ectopic secretion of corticotropin (ACTH) by a tumour is most likely to respond to somatostatin analogues if hypercortisolaemia has not yet developed.
引用
收藏
页码：516 / 516
页数：1
相关论文
共 50 条
  • [31] OCTREOTIDE AND INTERFERON ALFA - A NEW COMBINATION FOR THE TREATMENT OF MALIGNANT CARCINOID-TUMORS
    JANSON, EMT
    AHLSTROM, H
    ANDERSSON, T
    OBERG, KE
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (10) : 1647 - 1650
  • [32] Use of octreotide and lanreotide in the treatment of symptomatic non-resectable carcinoid tumours
    Rohaizak, M
    Farndon, JR
    ANZ JOURNAL OF SURGERY, 2002, 72 (09) : 635 - 638
  • [33] Comparison of Octreotide and Vasopressors as First-Line Treatment for Intraoperative Carcinoid Crisis
    McCully, Belinda H.
    Kozuma, Kaiya
    Pommier, SuEllen
    Pommier, Rodney F.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (05) : 2996 - 3002
  • [34] Comparison of Octreotide and Vasopressors as First-Line Treatment for Intraoperative Carcinoid Crisis
    Belinda H. McCully
    Kaiya Kozuma
    SuEllen Pommier
    Rodney F. Pommier
    Annals of Surgical Oncology, 2024, 31 : 2996 - 3002
  • [35] Serum chromogranin A reflects regression of metastatic carcinoid during prolonged octreotide treatment
    Pregun, Istvan
    Gergics, Peter
    Dabasi, Gabriella
    Igaz, Peter
    Racz, Karoly
    Tulassay, Zsolt
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (04) : 386 - 387
  • [36] Comparison of Octreotide and Vasopressors as First-Line Treatment for Intraoperative Carcinoid Crisis
    Ammann, Markus
    Kinney, Michelle A. O.
    Gudmundsdottir, Hallbera
    Santol, Jonas
    Thiels, Cornelius A.
    Warner, Susanne G.
    Truty, Mark J.
    Kendrick, Michael L.
    Smoot, Rory L.
    Anderson, Alexandra L.
    Halfdanarson, Thorvardur R.
    Nagorney, David M.
    Starlinger, Patrick P.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (06) : 3976 - 3977
  • [37] Mega-dose intravenous octreotide for the treatment of carcinoid crisis: a systematic review
    Seymour, Nicole
    Sawh, Sonja C.
    CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2013, 60 (05): : 492 - 499
  • [38] Effectiveness of long-term administration of octreotide LAR in a recurrent bronchial carcinoid with ectopic ACTH secretion
    Konstantinidi, O
    Tsagarakis, S
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152
  • [39] Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours
    Nilsson, O
    Kölby, L
    Wängberg, B
    Wigander, A
    Billig, H
    William-Olsson, L
    Fjälling, M
    Forssell-Aronsson, E
    Ahlman, H
    BRITISH JOURNAL OF CANCER, 1998, 77 (04) : 632 - 637
  • [40] Adding interferon-α to octreotide slows tumour progression compared with octreotide alone but evidence is lacking for improved survival in people with disseminated midgut carcinoid tumours
    Pape, UF
    Wiedenmann, B
    CANCER TREATMENT REVIEWS, 2003, 29 (06) : 565 - 569
12345